（R）-2-羟基戊二酸在异柠檬酸脱氢酶（IDH）突变型胶质瘤的肿瘤微环境中驱动免疫静止。 - Suppr

(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas.

作者信息

Richardson Leland G, Choi Bryan D, Curry William T

机构信息

Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

Transl Cancer Res. 2019 Mar;8(Suppl 2):S167-S170. doi: 10.21037/tcr.2019.01.08.

DOI:10.21037/tcr.2019.01.08

PMID:30956952

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6448779/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/776a/8798193/35116f6642c5/tcr-08-S2-S167-f1.jpg

相似文献

(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas.

Transl Cancer Res. 2019 Mar;8(Suppl 2):S167-S170. doi: 10.21037/tcr.2019.01.08.

D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells.

Clin Cancer Res. 2018 Nov 1;24(21):5381-5391. doi: 10.1158/1078-0432.CCR-17-3855. Epub 2018 Jul 13.

Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas.

Neuro Oncol. 2018 Aug 2;20(9):1262-1271. doi: 10.1093/neuonc/noy022.

IGFBP2 expression predicts IDH-mutant glioma patient survival.

Oncotarget. 2017 Jan 3;8(1):191-202. doi: 10.18632/oncotarget.13329.

Epigenetic Reprogramming for Targeting -Mutant Malignant Gliomas.

Cancers (Basel). 2019 Oct 22;11(10):1616. doi: 10.3390/cancers11101616.

Tissue 2-Hydroxyglutarate as a Biomarker for Mutations in Gliomas.

Clin Cancer Res. 2019 Jun 1;25(11):3366-3373. doi: 10.1158/1078-0432.CCR-18-3205. Epub 2019 Feb 18.

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.

J Clin Invest. 2017 Apr 3;127(4):1425-1437. doi: 10.1172/JCI90644. Epub 2017 Mar 20.

Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy.

Acta Neuropathol Commun. 2014 Nov 7;2:158. doi: 10.1186/s40478-014-0158-y.

Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 Tesla.

J Transl Med. 2016 Sep 22;14(1):274. doi: 10.1186/s12967-016-1035-1.

IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.

Neuro Oncol. 2016 Oct;18(10):1402-12. doi: 10.1093/neuonc/now061. Epub 2016 Apr 25.

引用本文的文献

Association between autologous formalin-fixed tumor vaccine (AFTV) therapy, molecular pathological markers, and survival outcomes in glioblastoma.

Brain Tumor Pathol. 2025 Aug 7. doi: 10.1007/s10014-025-00507-1.

A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma.

Cancers (Basel). 2025 Jun 27;17(13):2178. doi: 10.3390/cancers17132178.

Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma.

Clin Cancer Res. 2024 Sep 13;30(18):4068-4076. doi: 10.1158/1078-0432.CCR-24-1056.

Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.

Purinergic Signal. 2024 Feb;20(1):47-64. doi: 10.1007/s11302-023-09931-4. Epub 2023 Mar 24.

Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?

Cancers (Basel). 2023 Feb 7;15(4):1042. doi: 10.3390/cancers15041042.

Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.

Gut. 2023 Apr;72(4):736-748. doi: 10.1136/gutjnl-2021-326514. Epub 2022 May 18.

Metabolomics and the Multi-Omics View of Cancer.

Metabolites. 2022 Feb 7;12(2):154. doi: 10.3390/metabo12020154.

Simultaneous high PD-L1 and low VEGFR2 expression is associated with better overall survival in rectal cancer.

Transl Cancer Res. 2021 Jan;10(1):499-508. doi: 10.21037/tcr-20-3106.

Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients.

Ann Transl Med. 2021 Dec;9(24):1766. doi: 10.21037/atm-21-6011.

Microenvironmental Metabolites in the Intestine: Messengers between Health and Disease.

Metabolites. 2022 Jan 7;12(1):46. doi: 10.3390/metabo12010046.

本文引用的文献

Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate.

Nat Med. 2018 Aug;24(8):1192-1203. doi: 10.1038/s41591-018-0095-6. Epub 2018 Jul 9.

IDH mutational status and the immune system in gliomas: a tale of two tumors?

Transl Cancer Res. 2017 Oct;6(Suppl 7):S1253-S1256. doi: 10.21037/tcr.2017.09.37. Epub 2017 Sep 18.

Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.

Cancer. 2017 Dec 1;123(23):4535-4546. doi: 10.1002/cncr.31039. Epub 2017 Oct 5.

Isocitrate dehydrogenase mutation as a therapeutic target in gliomas.

Chin Clin Oncol. 2017 Jun;6(3):33. doi: 10.21037/cco.2017.06.11.

Correlation of immune phenotype with IDH mutation in diffuse glioma.

Neuro Oncol. 2017 Oct 19;19(11):1460-1468. doi: 10.1093/neuonc/nox054.

Mutant IDH1 regulates the tumor-associated immune system in gliomas.

Genes Dev. 2017 Apr 15;31(8):774-786. doi: 10.1101/gad.294991.116. Epub 2017 May 2.

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.

J Clin Invest. 2017 Apr 3;127(4):1425-1437. doi: 10.1172/JCI90644. Epub 2017 Mar 20.

Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.

J Neurooncol. 2016 Dec;130(3):517-527. doi: 10.1007/s11060-016-2245-3. Epub 2016 Sep 13.

Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase.

Clin Cancer Res. 2016 Dec 15;22(24):6256-6265. doi: 10.1158/1078-0432.CCR-15-2965. Epub 2016 Jun 23.

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

(R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献